Abstract

Objective:To investigate whether testing positive for human papilloma virus (HPV) in cervical screening has an impact on female sexual functioning.Materials and Methods:This study was designed as a single-center, prospective, descriptive-cross-sectional study and 300 women who received HPV testing in our hospital [HPV-positive (n=187) or HPV-negative (n=113)]. The Arizona Sexual Experiences (ASEX) scale and Female Sexual Functioning index (FSFI) were administered to study participants during face-to-face interviews.Results:No significant differences were found between women who were HPV-positive and HPV-negative in sexual functions as assessed using the ASEX and FSFI scales (p=0.343 and p=0.604, respectively). In addition, the analyses addressing whether sexual functioning was affected by a positive test result, at diagnosis or during the follow-up (before 2 weeks, 2 weeks-1 month, 1-3 months, 3-6 months, 6 months-1 year and over 1 year) revealed no significant differences between HPV-positive and HPV-negative women in sexual functioning (p>0.05). Sexual dysfunction was less common in married women than in the ASEX scale (p=0.03), and this difference was not detected when the FSFI scale was applied. The incidence of dysfunction was more frequent in working women than in retirees (p=0.006, p=0.01).Conclusion:Educational attainment, socioeconomic status, age, employment status, and marital status were found to have statistically significant effects on sexual functioning. Sexual functioning was affected by neither HPV test results (positive/negative) nor time from diagnosis.

Highlights

  • Female sexual function is defined as “the harmony in mind, senses and the individual’s body, which leads to the achievement of the personality, communication and love” (World Health Organization 2006)(1)

  • To investigate whether testing positive for human papilloma virus (HPV) in cervical screening has an impact on female sexual functioning

  • No significant differences were found between women who were HPV-positive and HPV-negative in sexual functions as assessed using the Arizona Sexual Experiences (ASEX) and Female Sexual Functioning index (FSFI) scales (p=0.343 and p=0.604, respectively)

Read more

Summary

Introduction

Female sexual function is defined as “the harmony in mind, senses and the individual’s body, which leads to the achievement of the personality, communication and love” (World Health Organization 2006)(1). Female sexual dysfunction is described as libido abnormalities, stimulation and orgasm problems, along with sexual pain[2]. In Turkey, the prevalence of sexual dysfunction in women has been reported to range between 46.9% and 48.3%(3,4). Sexual function is affected by many factors such as menstruation, pregnancy, lactation, anogenital lesions, cancer, chronic systemic diseases, infertility, any conditions that might lead to sexual dysfunction including vaginismus, vaginal atrophy, vaginal stenosis, active vaginitis, hymenal stenosis, depression, use of any medicines, and alcohol and/or any chemical substance addiction[5,6,7]. An HPV screening program has been conducted in Turkey since 2009. The aim of this study was to investigate sociodemographic factors affecting female dysfunction along with HPV screening results

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call